When expressed in Xenopus oocytes, the rat ␣7 subunit forms homo-oligomeric nicotinic acetylcholine receptors, which are blocked by ␣-bungarotoxin. Since the pharmacological and physiological properties of the ␣7 receptor expressed in oocytes are similar to those of the ␣-bungarotoxin-sensitive nicotinic currents recorded from neuronal preparations and the distribution patterns of ␣7 mRNA and ␣-bungarotoxin-binding sites in the rat brain are very similar, ␣7 is thought to be the main component of the ␣-bungarotoxin-binding nicotinic receptor in the mammalian brain. However, while ␣7 is found in purified ␣-bungarotoxin-binding complexes from rat brain or PC12 cells, other proteins copurify with it. Therefore, the question whether ␣7 forms a homo-oligomeric ␣-bungarotoxin-binding nicotinic receptor in the mammalian brain remains. We have developed and characterized affinity-purified polyclonal antibodies and used these antibodies in Western blot analyses of ␣-bungarotoxin-binding proteins purified from rat brains. We report here that our experimental data support the current working hypothesis that the ␣-bungarotoxin-binding nicotinic receptor is a homooligomer of ␣7 subunits in the rat brain.␣-Bungarotoxin (␣-BTX), 1 a snake toxin that binds to the muscle-type nicotinic acetylcholine receptor (nAChR), also binds to the surface of sympathetic ganglion cells, cultured PC12 cells (rat pheochromocytoma cells), and brain membranes. The ␣-BTX-binding sites in these preparations are distinct subpopulations of the neuronal nAChRs. This conclusion is based on the observations that 1) the ␣-BTX-sensitive nAChRs have a relatively low affinity for nicotine in comparison with the ␣-BTX-insensitive receptors (1); 2) the anatomical distribution of ␣-BTX-binding sites and nicotine-binding sites in the brain is highly distinct (2); 3) ␣-BTX binds to the surface of PC12 cells, but fails to block nicotinic agonist-mediated responses in these cells (3-5); and 4) ␣-BTX-sensitive and -insensitive nicotinic receptors in PC12 cells and in the brain can be distinguished immunologically (6, 7).The molecular basis for these differences have been revealed by cloning the genes encoding subunits of the neuronal nAChRs (for reviews, see Ref. 8). In the rat, 10 genes encoding neuronal nAChR subunits have been identified to date. Seven encode ␣ subunits (␣2-␣7 and ␣9), and three encode  subunits (2-4). When expressed in Xenopus oocytes, only ␣7 and ␣9 form homo-oligomeric nAChRs, and activation of these receptors can be blocked by ␣-BTX (9, 10). Since in situ hybridization has shown the ␣9 subunit to be present in hair cells but not in the brain and the ␣9 receptor expressed in oocytes has unique pharmacological properties that are similar to those of the cholinergic receptor observed in vertebrate cochlear hair cells, the ␣9 receptor is thought to be involved primarily in the cholinergic efferent innervation of the cochlear hair cells (10). On the other hand, ␣7 mRNA is widely expressed in the rat brain and is thought to be the main componen...